272 related articles for article (PubMed ID: 2143956)
1. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
Yamada H; Yoneyama F; Satoh K; Taira N
Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
[TBL] [Abstract][Full Text] [Related]
2. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
Satoh E; Yanagisawa T; Taira N
Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209
[TBL] [Abstract][Full Text] [Related]
3. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
Satoh K; Yamada H; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
[TBL] [Abstract][Full Text] [Related]
4. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.
Yoneyama F; Satoh K; Taira N
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1119-26. PubMed ID: 2150593
[TBL] [Abstract][Full Text] [Related]
5. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
Imagawa J; Akima M; Nabata H; Taira N
J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological analysis of the vasodepressor effect of KRN2391 in pithed rats.
Tanaka Y; Yokoyama T; Kashiwabara T; Fukushima H; Izawa T; Ogawa N
Gen Pharmacol; 1993 Nov; 24(6):1379-81. PubMed ID: 8112509
[TBL] [Abstract][Full Text] [Related]
7. Nicorandil as a nitrate, and cromakalim as a potassium channel opener, dilate isolated porcine large coronary arteries in an agonist-nonselective manner.
Satoh K; Mori T; Yamada H; Taira N
Cardiovasc Drugs Ther; 1993 Aug; 7(4):691-9. PubMed ID: 8241013
[TBL] [Abstract][Full Text] [Related]
8. Effect of KRN2391 on venous return: comparison with other vasodilators.
Kaneta S; Jinno Y; Miwa A; Fukushima H; Ogawa N
J Cardiovasc Pharmacol; 1993 Jul; 22(1):82-8. PubMed ID: 7690101
[TBL] [Abstract][Full Text] [Related]
9. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
Yanagisawa T; Teshigawara T; Taira N
Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
[TBL] [Abstract][Full Text] [Related]
11. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery.
Abe S; Nishimura J; Nakamura M; Kanaide H
J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988
[TBL] [Abstract][Full Text] [Related]
12. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
Kamijo T; Tomaru T; Miwa A; Nakamura F; Kido H; Sugimoto T; Uchida Y
Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.
Nakae I; Quan L; Hashimoto K; Sugimoto Y; Tsutamoto T; Kinoshita M
Cardiovasc Drugs Ther; 1994 Feb; 8(1):137-45. PubMed ID: 8086324
[TBL] [Abstract][Full Text] [Related]
14. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
Fujiwara T; Angus JA
Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
[TBL] [Abstract][Full Text] [Related]
15. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
Cavero I; Pratz J; Mondot S
Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
[TBL] [Abstract][Full Text] [Related]
16. The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.
Kreye VA; Lenz T; Theiss U
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):70-5. PubMed ID: 1827659
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim.
Saito K; Sakai K
Fundam Clin Pharmacol; 1998; 12(1):37-43. PubMed ID: 9523182
[TBL] [Abstract][Full Text] [Related]
18. Effects of K-channel openers on the contractility and electrical activity of antral circular muscle in guinea-pig stomach.
Kim KW; Kim SJ; Jun JY
J Smooth Muscle Res; 1993 Oct; 29(5):145. PubMed ID: 8167416
[No Abstract] [Full Text] [Related]
19. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
